330 related articles for article (PubMed ID: 25625843)
1. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression.
Mäki-Nevala S; Valo S; Ristimäki A; Sarhadi V; Knuutila S; Nyström M; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Peltomäki P
EBioMedicine; 2019 Jan; 39():280-291. PubMed ID: 30578081
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.
Bonito NA; Borley J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Brown R
Clin Cancer Res; 2016 Jun; 22(12):3097-3104. PubMed ID: 26763252
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
8. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
Dai W; Teodoridis JM; Zeller C; Graham J; Hersey J; Flanagan JM; Stronach E; Millan DW; Siddiqui N; Paul J; Brown R
Clin Cancer Res; 2011 Jun; 17(12):4052-62. PubMed ID: 21459799
[TBL] [Abstract][Full Text] [Related]
9. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract][Full Text] [Related]
10. Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis.
Mäki-Nevala S; Ukwattage S; Wirta EV; Ahtiainen M; Ristimäki A; Seppälä TT; Lepistö A; Mecklin JP; Peltomäki P
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680073
[TBL] [Abstract][Full Text] [Related]
11. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
[TBL] [Abstract][Full Text] [Related]
12. Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines.
Losi L; Lauriola A; Tazzioli E; Gozzi G; Scurani L; D'Arca D; Benhattar J
J Ovarian Res; 2019 Jul; 12(1):62. PubMed ID: 31291979
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Hsu Lin L; Allison DHR; Turashvili G; Vasudevaraja V; Tran I; Serrano J; Weigelt B; Ladanyi M; Abu-Rustum NR; Snuderl M; Chiang S
Mod Pathol; 2023 Nov; 36(11):100321. PubMed ID: 37652400
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic activation of POTE genes in ovarian cancer.
Sharma A; Albahrani M; Zhang W; Kufel CN; James SR; Odunsi K; Klinkebiel D; Karpf AR
Epigenetics; 2019 Feb; 14(2):185-197. PubMed ID: 30764732
[TBL] [Abstract][Full Text] [Related]
15. Development of high‑resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinoma.
Vaclavikova R; Klajic J; Brynychova V; Elsnerova K; Alnaes GIG; Tost J; Kristensen VN; Rob L; Kodet R; Skapa P; Mrhalova M; Soucek P
Oncol Rep; 2019 Aug; 42(2):763-774. PubMed ID: 31173253
[TBL] [Abstract][Full Text] [Related]
16. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
17. [The pathology of hereditary ovarian tumors].
Pesce F; Devouassoux-Shisheboran M
Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
[TBL] [Abstract][Full Text] [Related]
18. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
Kim JY; Kim SH; Kim HS
Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
[TBL] [Abstract][Full Text] [Related]
19. Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.
Bodelon C; Killian JK; Sampson JN; Anderson WF; Matsuno R; Brinton LA; Lissowska J; Anglesio MS; Bowtell DDL; Doherty JA; Ramus SJ; Talhouk A; Sherman ME; Wentzensen N
Clin Cancer Res; 2019 Oct; 25(19):5937-5946. PubMed ID: 31142506
[TBL] [Abstract][Full Text] [Related]
20. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M
J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
